Follow the people · Insider

RR

Rosty Raykov

Insider · Other role · FENC

Rosty Raykov files insider transactions with the SEC as a chief executive officer of Fennec Pharmaceuticals (FENC). We hold 9 disclosed purchases and sales filed since 20 August 2010, 3 of them in the last 90 days.

  • Files forFENC
  • Disclosed buys and sells9 in all, 3 in the last 90 days
  • Last disclosure1 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 6 February 20181 September 2026Chief Executive Officer · Fennec Pharmaceuticals (FENC)136 Form 4 lines · source: SEC Form 4
  • Filed 18 August 201018 August 2010Na · Adherex Technologies (ADHXF)1 Form 4 line · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.